Skip to main content
. 2018 Aug 2;10(8):1009. doi: 10.3390/nu10081009

Table 2.

Anti-diabetic effects of honey in clinical and pre-clinical studies.

Author Honey Sources/Types Dose Duration Models Results
Aziz et al. (2017) [13] Stingless bee honey 1.0 or 2.0 g/kg/day 28 days Male Sprague-Dawley rats Treatment of 1.0 g/kg/day honey resulted in a modest decrease of fasting blood sugar (FBS) level at the end of study duration.
Honey administration at the dose of 2.0 g/kg/day caused marked reduction of FBS after 28 days.
Treatment with both 1.0 and 2.0 g/kg/day of honey:
Protected against shrinkage of the pancreatic islets sizes.
Significantly elevated the serum insulin level.
Markedly increased insulin intensity in the pancreatic islets (as seen in the immunohistochemistry analysis).
Bahrami et al. (2009) [34] Natural, unprocessed honey (obtained from Samans kandeh, Neka, Sari City, Iran) 1st 14 days: 1.0 g/kg/day
2nd 14 days: 1.5 g/kg/day
3rd 14 days: 2.0 g/kg/day
4th 14 days: 2.5 g/kg/day
56 days 48 type II diabetic patients Patients receiving honey were observed to have significant reduction of fasting blood sugar level after 56 days treatment compared to baseline (124.3 ± 37.5 vs. 153.3 ± 43.9 mg/dL, respectively; p = 0.01).
Öztaşan et al. (2005) [40] Mad honey 50 mg/kg/day (2 mL mad honey dissolved in distilled water) 3 days Male albino Wister rats Post-treatment blood glucose level (after administration of mad honey for 3 consecutive days) was markedly reduced in both streptozotocin-induced diabetic rats and control groups.
Hemmati et al. (2015) [46] Honey from jujube plant area, in South Khorasan, Iran 1.0 g and 2.0 g/kg body weight/day 21 days Adult male Wistar rats Diabetic rats supplemented with honey (1 and 2 g/kg) had significantly lower FBS (7.8 ± 0.12 mmol/L and 9.03 ± 0.15 mmol/L, respectively) than diabetic control rats (31.1 ± 2.3 mmol/L).
Honey significantly increased serum adiponectin (4.5 ± 0.26 mg/L) levels in diabetic rats.
Erejuwa et al. (2010) [49] Tualang honey 1.0 g/kg 28 days Male Sprague-Dawley rats Rats treated with honey had significant lower FBS (median (IQR): 8.8 (5.8) mmol/L) compared to diabetic rats given distilled water (median (IQR): 17.9 (2.6) mmol/L).
Erejuwa et al. (2016) [50] Natural honey (supplied by Ebonyi State, Nigeria) 1.0, 2.0 or 3.0 g/kg body weight/day 21 days Wistar rats Honey supplementation at 1.0 and 2.0 g/kg/day significantly reduced FBS level in diabetic rats induced with alloxan (p < 0.05).
Sheriff et al. (2011) [51] Unknown honey species 1.0 mL/200 g body weight 7 days Male albino rats Treatment with honey resulted in a non-significant reduction of FBS and 2 hour postprandial glucose level compared with untreated alloxan-induced DM rats (8.44 ± 1.66 and 11.05 ± 2.11 mmol/L vs. 11.57 ± 2.22 and 16.45 ± 3.11 mmol/L, respectively).
Arabmoazzen et al. (2015) [52] Honey from a bee keeping center of Urmia city, Iran 3 mL/kg, 5% honey solution given 3 times/day 56 days Adult male Wistar rats After 56th days, serum glucose concentration of noise-induced diabetic rats treated with honey had a significant lower concentration (208 ± 34.6 mg/dL) (p < 0.01) compared to untreated diabetic rats.
Honey-treated rats had a larger diameter of the Langerhans islands in the pancreas compared to diabetic control (5.6 ± 154.5 vs. 4.75 ± 54.25 μm)
Al-Waili (2004) [53] Natural honey 90 g honey in 250 mL water. Once (30 min prior to blood sampling) 7 patients of type II DM Patients with type II DM had significantly lowered blood glucose elevation when administered with honey compared to dextrose.
Krishnasree & Mary (2017) [59] Multifloral honey (Apis cerana indica F., Apis mellifera L., Apis dorsata F., Apis florea F. and Trigona iridipennis S.) 100–500 μg/mL concentration - In vitro assays for α-amylase and α-glucosidase inhibitory activities Trigona iridipennis honey had the strongest α-amylase and α-glucosidase inhibitory properties compared to other multifloral honey species.
Inhibition of α-amylase enzyme was comparable to standard diabetic therapy by acarbose especially the highest concentration of 500 μg/mL.

DM, diabetes mellitus; FBS, fasting blood sugar; IQR, interquartile range.